Skip to main content

Table 6 Antimicrobial susceptibility patterns of Gram-negative bacterial isolates from wound swab cultures among dog bite patients reporting to two DBW care centers in Uganda in the period March 2019–October 2019

From: The potential for the double risk of rabies and antimicrobial resistance in a high rabies endemic setting: detection of antibiotic resistance in bacterial isolates from infected dog bite wounds in Uganda

Bacteria

Number of isolates that are resistant to antimicrobial agent, n (%)

CRO

MET

CN

AML

SXT

CIP

IPM

S

DOX

OX

C

AMP

Pasteurella

P. maltocida (n = 64)

0 (0.0)

64 (100.0)

0 (0.0)

12 (18.8)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

6 (9.4)

0 (0.0)

8 (12.5)

P. canis (n = 26)

0 (0.0)

26 (100.0)

0 (0.0)

7 (26.9)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

10 (38.5)

Other pasteurella (n = 31)

0 (0.0)

31 (100.0)

3 (9.7)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Proteus

P. vulgaris (n = 2)

0 (0.0)

2 (100.0)

0 (0.0)

2 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

2 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

P. mirabilis (n = 7)

0 (0.0)

7 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

3 (42.9)

4 (57.1)

2 (28.6)

0 (0.0)

3 (42.9)

Pseudomonas

P. aeuroginosa (n = 3)

0 (0.0)

3 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

3 (100.0)

P. stutzeri (n = 3)

0 (0.0)

3 (100.0)

0 (0.0)

1 (33.3)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

3 (100.0)

0 (0.0)

0 (0.0)

P. alcaligenes (n = 2)

1 (50.0)

2 (100.0)

1 (50.0)

1 (50.0)

0 (0.0)

0 (0.0)

1(50.0)

2 (100.0)

2 (100.0)

2 (100.0)

0 (0.0)

2 (100.0)

Other pseudomonas* (n = 11)

0 (0.0)

11 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

3 (27.3)

0 (0.0)

11 (100.0)

2 (18.1)

3 (27.3)

Klebsiella

K. pneumonae (n = 11)*

2 (18.1)

11 (100.0)

0 (0.0)

11 (100.0)

5 (45.5)

0 (0.0)

0 (0.0)

0 (0.0)

7 (63.6)

11 (100.0)

3 (27.3)

11 (100.0)

K. oxytoca (n = 6)

0 (0.0)

6 (100.0)

4 (66.7)

6 (100.0)

4 (66.7)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

6 (100.0)

0 (0.0)

6 (100.0)

Acinetobacter spp (n = 3)

0 (0.0)

3 (100.0)

0 (0.0)

0 (0.0)

3(100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

3 (100.0)

0 (0.0)

3 (100.0)

Moellerella wisconsensis (n = 5)

3 (60.0)

5 (100.0)

0 (0.0)

5 (100.0)

3 (60.0)

0 (0.0)

0 (0.0)

0 (0.0)

3 (60.0)

5 (100.0)

2 (40.0)

5 (100.0)

Capnocytophaga canimorsus (n = 36)

11 (30.6)

36 (100.0)

0 (0.0)

16 (44.4)

15 (41.7)

0 (0.0)

0 (0.0)

5 (13.9)

0 (0.0)

34 (94.4)

10 (27.8)

31 (86.1)

Stenotrophomonas maltophilia (n = 4)

0 (0.0)

4 (100.0)

1 (25.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Bergeyella zoohelcum (n = 3)

0 (0.0)

3 (100.0)

0 (0.0)

3 (100.0)

3 (100.0)

0 (0.0)

0 (0.0)

3 (100.0)

3 (100.0)

0 (0.0)

0 (0.0)

3 (100.0)

Citrobacter

C. werkmanii (n = 1)

0 (0.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (100.0)

0 (0.0)

0 (0.0)

1 (100.0)

C. freundii (n = 2)

2 (100.0)

2 (100.0)

0 (0.0)

1 (50.0)

2 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (100.0)

1 (100.0)

2 (100.0)

2 (100.0)

E. coli (n = 6)

0 (0.0)

6 (100.0)

0 (0.0)

4 (66.7)

6 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

4 (66.7)

6 (100.0)

0 (0.0)

4 (66.7)

Enterobacter

E. asburiae (n = 1)

0 (0.0)

1 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (100.0)

1 (100.0)

1 (100.0)

0 (0.0)

Other enterobacter spp (n = 13)

7 (53.9)

13 (100.0)

0 (0.0)

6 (46.2)

13 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

7 (53.9)

13 (100.0)

0 (0.0)

13 (100.0)

Serratia

S. rubidae (n = 2)

0 (0.0)

2 (100.0)

0 (0.0)

2 (100.0)

2 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

S. entomophila (n = 3)

0 (0.0)

3 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

3 (100.0)

Fusobacterium spp (n = 48)

0 (0.0)

48 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

8 (16.7)

0 (0.0)

0 (0.0)

0 (0.0)

Bacteriodes spp (n = 34)

0 (0.0)

34 (100.0)

4 (11.8)

1 (2.9)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

28 (82.4)

2 (5.9)

0 (0.0)

0 (0.0)

Prevotella spp (n = 35)

0 (0.0)

35 (100.0)

0 (0.0)

6 (17.1)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

12 (34.3)

0 (0.0)

0 (0.0)

0 (0.0)

Total isolates N = 362

26 (7.2)

362 (100)

13 (5.3)

54 (14.9)

53 (14.6)

0 (0.0)

1 (0.3)

16 (4.4)

83 (22.9)

106 (29.3)

20 (5.5)

111 (30.7)

  1. CRO ceftriaxone; ME metronidazole; CN gentamycin; AML amoxicillin / clavulanic acid; SXT trimethoprim / sulfamethoxazoleI; VA vancomycin; CIP ciprofloxacin; IPM imipenem; S streptomycin; DOX doxycycline; OX oxacillin; C chloramphenicol; AMP ampicillin
  2. The antimicrobial susceptibility patterns of the Gram-negative bacterial isolates from DBWs. The predominant gram negative isolates were P. maltocida (n = 64), P. canis (n = 26) and Capnocytophaga canimorsus (n = 36). P. maltocida was highly resistant to metronidazole (64, 100%) but low resistance to gentamycin (6, 9.4%), amoxicillin (12, 18.8%), ampicillin (8, 12.5%) and oxacillin (6, 9.4%). It was susceptible to all other antimicrobial drugs. However, much as P. canis was highly resistant to metronidazole (26, 100%), the resistance to amoxicillin (7, 26.9%), and ampicillin (10, 38.5%) was substantially low
Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us